Skip to main content

No Evidence of Disease clinical trials at UC Health
3 in progress, 0 open to new patients

  • Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer

    Sorry, in progress, not accepting new patients

    This pilot clinical trial studies a culturally-informed counseling intervention in Latinas at high risk for hereditary breast or ovarian cancer. A culturally-informed counseling intervention may be an effective method to help people learn more about their cancer risk.

    at UCLA

  • Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

    Sorry, in progress, not accepting new patients

    This randomized phase III trial studies how well pazopanib hydrochloride works compared to placebo in treating patients with kidney cancer that has spread to other parts of the body and have no evidence of disease after surgery. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

    at UCSD

  • Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

    Sorry, in progress, not accepting new patients

    This phase IIA trial studies how well a recombinant human papillomavirus nonavalent works in preventing human papilloma virus (HPV) in younger healthy participants. HPV is a common virus which usually causes infections that last only a few months, but sometimes can last a long time and cause cancers of the cervix, vagina, vulva, anus or oropharynx over many years among adults. Recombinant human papillomavirus nonavalent vaccine is a type of nonavalent vaccine (a vaccine that works against nine different viruses or other microorganisms) and may protect against HPV infection and the health problems that HPV infection can cause.

    at UCLA